Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Amiodarone market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Amiodarone market. Detailed analysis of key players, along with key growth strategies adopted by Amiodarone industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi
Cipla Pharmaceutical
Roemmers
Harbin Pharmaceutical Group
Wyeth Pharmaceuticals (Pfizer)
North China Pharmaceutical Company
Sawai Pharmaceutical
Mylan Pharmaceuticals
Arrow Pharma Pty Ltd
Shanghai Pharmaceuticals
By Type:
Tablet
Capsule
Injection
By End-User:
Cardiac Arrest
Ventricular Tachycardia
Atrial Fibrillation
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Amiodarone Market
-
1.3 Market Segment by Type
-
1.3.1 China Amiodarone Market Size and Growth Rate of Tablet from 2016 to 2027
-
1.3.2 China Amiodarone Market Size and Growth Rate of Capsule from 2016 to 2027
-
1.3.3 China Amiodarone Market Size and Growth Rate of Injection from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Amiodarone Market Size and Growth Rate of Cardiac Arrest from 2016 to 2027
-
1.4.2 China Amiodarone Market Size and Growth Rate of Ventricular Tachycardia from 2016 to 2027
-
1.4.3 China Amiodarone Market Size and Growth Rate of Atrial Fibrillation from 2016 to 2027
-
1.4.4 China Amiodarone Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Amiodarone Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Amiodarone by Major Types
-
3.4.1 Market Size and Growth Rate of Tablet
-
3.4.2 Market Size and Growth Rate of Capsule
-
3.4.3 Market Size and Growth Rate of Injection
4 Segmentation of Amiodarone Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Amiodarone by Major End-Users
-
4.4.1 Market Size and Growth Rate of Amiodarone in Cardiac Arrest
-
4.4.2 Market Size and Growth Rate of Amiodarone in Ventricular Tachycardia
-
4.4.3 Market Size and Growth Rate of Amiodarone in Atrial Fibrillation
-
4.4.4 Market Size and Growth Rate of Amiodarone in Others
5 Market Analysis by Regions
-
5.1 China Amiodarone Production Analysis by Regions
-
5.2 China Amiodarone Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Amiodarone Landscape Analysis
-
6.1 North China Amiodarone Landscape Analysis by Major Types
-
6.2 North China Amiodarone Landscape Analysis by Major End-Users
7 Central China Amiodarone Landscape Analysis
-
7.1 Central China Amiodarone Landscape Analysis by Major Types
-
7.2 Central China Amiodarone Landscape Analysis by Major End-Users
8 South China Amiodarone Landscape Analysis
-
8.1 South China Amiodarone Landscape Analysis by Major Types
-
8.2 South China Amiodarone Landscape Analysis by Major End-Users
9 East China Amiodarone Landscape Analysis
-
9.1 East China Amiodarone Landscape Analysis by Major Types
-
9.2 East China Amiodarone Landscape Analysis by Major End-Users
10 Northeast China Amiodarone Landscape Analysis
-
10.1 Northeast China Amiodarone Landscape Analysis by Major Types
-
10.2 Northeast China Amiodarone Landscape Analysis by Major End-Users
11 Southwest China Amiodarone Landscape Analysis
-
11.1 Southwest China Amiodarone Landscape Analysis by Major Types
-
11.2 Southwest China Amiodarone Landscape Analysis by Major End-Users
12 Northwest China Amiodarone Landscape Analysis
-
12.1 Northwest China Amiodarone Landscape Analysis by Major Types
-
12.2 Northwest China Amiodarone Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Sanofi
-
13.1.1 Sanofi Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Cipla Pharmaceutical
-
13.2.1 Cipla Pharmaceutical Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Roemmers
-
13.3.1 Roemmers Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Harbin Pharmaceutical Group
-
13.4.1 Harbin Pharmaceutical Group Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Wyeth Pharmaceuticals (Pfizer)
-
13.5.1 Wyeth Pharmaceuticals (Pfizer) Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 North China Pharmaceutical Company
-
13.6.1 North China Pharmaceutical Company Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Sawai Pharmaceutical
-
13.7.1 Sawai Pharmaceutical Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Mylan Pharmaceuticals
-
13.8.1 Mylan Pharmaceuticals Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Arrow Pharma Pty Ltd
-
13.9.1 Arrow Pharma Pty Ltd Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Shanghai Pharmaceuticals
-
13.10.1 Shanghai Pharmaceuticals Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Amiodarone Market Size and Growth Rate of Tablet from 2016 to 2027
-
Figure China Amiodarone Market Size and Growth Rate of Capsule from 2016 to 2027
-
Figure China Amiodarone Market Size and Growth Rate of Injection from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Amiodarone Market Size and Growth Rate of Cardiac Arrest from 2016 to 2027
-
Figure China Amiodarone Market Size and Growth Rate of Ventricular Tachycardia from 2016 to 2027
-
Figure China Amiodarone Market Size and Growth Rate of Atrial Fibrillation from 2016 to 2027
-
Figure China Amiodarone Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Amiodarone Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Amiodarone Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Amiodarone
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Amiodarone by Different Types from 2016 to 2027
-
Table Consumption Share of Amiodarone by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Tablet
-
Figure Market Size and Growth Rate of Capsule
-
Figure Market Size and Growth Rate of Injection
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Amiodarone by Different End-Users from 2016 to 2027
-
Table Consumption Share of Amiodarone by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Cardiac Arrest
-
Figure Market Size and Growth Rate of Ventricular Tachycardia
-
Figure Market Size and Growth Rate of Atrial Fibrillation
-
Figure Market Size and Growth Rate of Others
-
Table China Amiodarone Production by Regions
-
Table China Amiodarone Production Share by Regions
-
Figure China Amiodarone Production Share by Regions in 2016
-
Figure China Amiodarone Production Share by Regions in 2021
-
Figure China Amiodarone Production Share by Regions in 2027
-
Table China Amiodarone Consumption by Regions
-
Table China Amiodarone Consumption Share by Regions
-
Figure China Amiodarone Consumption Share by Regions in 2016
-
Figure China Amiodarone Consumption Share by Regions in 2021
-
Figure China Amiodarone Consumption Share by Regions in 2027
-
Table North China Amiodarone Consumption by Types from 2016 to 2027
-
Table North China Amiodarone Consumption Share by Types from 2016 to 2027
-
Figure North China Amiodarone Consumption Share by Types in 2016
-
Figure North China Amiodarone Consumption Share by Types in 2021
-
Figure North China Amiodarone Consumption Share by Types in 2027
-
Table North China Amiodarone Consumption by End-Users from 2016 to 2027
-
Table North China Amiodarone Consumption Share by End-Users from 2016 to 2027
-
Figure North China Amiodarone Consumption Share by End-Users in 2016
-
Figure North China Amiodarone Consumption Share by End-Users in 2021
-
Figure North China Amiodarone Consumption Share by End-Users in 2027
-
Table Central China Amiodarone Consumption by Types from 2016 to 2027
-
Table Central China Amiodarone Consumption Share by Types from 2016 to 2027
-
Figure Central China Amiodarone Consumption Share by Types in 2016
-
Figure Central China Amiodarone Consumption Share by Types in 2021
-
Figure Central China Amiodarone Consumption Share by Types in 2027
-
Table Central China Amiodarone Consumption by End-Users from 2016 to 2027
-
Table Central China Amiodarone Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Amiodarone Consumption Share by End-Users in 2016
-
Figure Central China Amiodarone Consumption Share by End-Users in 2021
-
Figure Central China Amiodarone Consumption Share by End-Users in 2027
-
Table South China Amiodarone Consumption by Types from 2016 to 2027
-
Table South China Amiodarone Consumption Share by Types from 2016 to 2027
-
Figure South China Amiodarone Consumption Share by Types in 2016
-
Figure South China Amiodarone Consumption Share by Types in 2021
-
Figure South China Amiodarone Consumption Share by Types in 2027
-
Table South China Amiodarone Consumption by End-Users from 2016 to 2027
-
Table South China Amiodarone Consumption Share by End-Users from 2016 to 2027
-
Figure South China Amiodarone Consumption Share by End-Users in 2016
-
Figure South China Amiodarone Consumption Share by End-Users in 2021
-
Figure South China Amiodarone Consumption Share by End-Users in 2027
-
Table East China Amiodarone Consumption by Types from 2016 to 2027
-
Table East China Amiodarone Consumption Share by Types from 2016 to 2027
-
Figure East China Amiodarone Consumption Share by Types in 2016
-
Figure East China Amiodarone Consumption Share by Types in 2021
-
Figure East China Amiodarone Consumption Share by Types in 2027
-
Table East China Amiodarone Consumption by End-Users from 2016 to 2027
-
Table East China Amiodarone Consumption Share by End-Users from 2016 to 2027
-
Figure East China Amiodarone Consumption Share by End-Users in 2016
-
Figure East China Amiodarone Consumption Share by End-Users in 2021
-
Figure East China Amiodarone Consumption Share by End-Users in 2027
-
Table Northeast China Amiodarone Consumption by Types from 2016 to 2027
-
Table Northeast China Amiodarone Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Amiodarone Consumption Share by Types in 2016
-
Figure Northeast China Amiodarone Consumption Share by Types in 2021
-
Figure Northeast China Amiodarone Consumption Share by Types in 2027
-
Table Northeast China Amiodarone Consumption by End-Users from 2016 to 2027
-
Table Northeast China Amiodarone Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Amiodarone Consumption Share by End-Users in 2016
-
Figure Northeast China Amiodarone Consumption Share by End-Users in 2021
-
Figure Northeast China Amiodarone Consumption Share by End-Users in 2027
-
Table Southwest China Amiodarone Consumption by Types from 2016 to 2027
-
Table Southwest China Amiodarone Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Amiodarone Consumption Share by Types in 2016
-
Figure Southwest China Amiodarone Consumption Share by Types in 2021
-
Figure Southwest China Amiodarone Consumption Share by Types in 2027
-
Table Southwest China Amiodarone Consumption by End-Users from 2016 to 2027
-
Table Southwest China Amiodarone Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Amiodarone Consumption Share by End-Users in 2016
-
Figure Southwest China Amiodarone Consumption Share by End-Users in 2021
-
Figure Southwest China Amiodarone Consumption Share by End-Users in 2027
-
Table Northwest China Amiodarone Consumption by Types from 2016 to 2027
-
Table Northwest China Amiodarone Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Amiodarone Consumption Share by Types in 2016
-
Figure Northwest China Amiodarone Consumption Share by Types in 2021
-
Figure Northwest China Amiodarone Consumption Share by Types in 2027
-
Table Northwest China Amiodarone Consumption by End-Users from 2016 to 2027
-
Table Northwest China Amiodarone Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Amiodarone Consumption Share by End-Users in 2016
-
Figure Northwest China Amiodarone Consumption Share by End-Users in 2021
-
Figure Northwest China Amiodarone Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Cipla Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Cipla Pharmaceutical
-
Figure Revenue and Market Share Analysis of Cipla Pharmaceutical
-
Table Product and Service Introduction of Cipla Pharmaceutical
-
Table Company Profile and Development Status of Roemmers
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roemmers
-
Figure Sales and Growth Rate Analysis of Roemmers
-
Figure Revenue and Market Share Analysis of Roemmers
-
Table Product and Service Introduction of Roemmers
-
Table Company Profile and Development Status of Harbin Pharmaceutical Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Harbin Pharmaceutical Group
-
Figure Sales and Growth Rate Analysis of Harbin Pharmaceutical Group
-
Figure Revenue and Market Share Analysis of Harbin Pharmaceutical Group
-
Table Product and Service Introduction of Harbin Pharmaceutical Group
-
Table Company Profile and Development Status of Wyeth Pharmaceuticals (Pfizer)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wyeth Pharmaceuticals (Pfizer)
-
Figure Sales and Growth Rate Analysis of Wyeth Pharmaceuticals (Pfizer)
-
Figure Revenue and Market Share Analysis of Wyeth Pharmaceuticals (Pfizer)
-
Table Product and Service Introduction of Wyeth Pharmaceuticals (Pfizer)
-
Table Company Profile and Development Status of North China Pharmaceutical Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of North China Pharmaceutical Company
-
Figure Sales and Growth Rate Analysis of North China Pharmaceutical Company
-
Figure Revenue and Market Share Analysis of North China Pharmaceutical Company
-
Table Product and Service Introduction of North China Pharmaceutical Company
-
Table Company Profile and Development Status of Sawai Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sawai Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Sawai Pharmaceutical
-
Figure Revenue and Market Share Analysis of Sawai Pharmaceutical
-
Table Product and Service Introduction of Sawai Pharmaceutical
-
Table Company Profile and Development Status of Mylan Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Mylan Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Mylan Pharmaceuticals
-
Table Product and Service Introduction of Mylan Pharmaceuticals
-
Table Company Profile and Development Status of Arrow Pharma Pty Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrow Pharma Pty Ltd
-
Figure Sales and Growth Rate Analysis of Arrow Pharma Pty Ltd
-
Figure Revenue and Market Share Analysis of Arrow Pharma Pty Ltd
-
Table Product and Service Introduction of Arrow Pharma Pty Ltd
-
Table Company Profile and Development Status of Shanghai Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Shanghai Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Shanghai Pharmaceuticals
-
Table Product and Service Introduction of Shanghai Pharmaceuticals
-
